Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Herestraat 49, O&NI bis, box 706, 3000, Leuven, Belgium.
Laboratory of Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.
Respir Res. 2021 Mar 17;22(1):86. doi: 10.1186/s12931-021-01680-5.
Chronic obstructive pulmonary disease (COPD) is characterized by a progressive and abnormal inflammatory response in the lungs, mainly caused by cigarette smoking. Animal models exposed to cigarette smoke (CS) are used to mimic human COPD but the use of different CS protocols makes it difficult to compare the immunological and structural consequences of using a nose-only or whole-body CS exposure system. We hypothesized that when using a standardized CS exposure protocol based on particle density and CO (carbon monoxide) levels, the whole-body CS exposure system would generate a more severe inflammatory response than the nose-only system, due to possible sensitization by uptake of CS-components through the skin or via grooming.
In this study focusing on early COPD, mice were exposed twice daily 5 days a week to CS either with a nose-only or whole-body exposure system for 14 weeks to assess lung function, remodeling and inflammation.
At sacrifice, serum cotinine levels were significantly higher in the whole-body (5.3 (2.3-6.9) ng/ml) compared to the nose-only ((2.0 (1.8-2.5) ng/ml) exposure system and controls (1.0 (0.9-1.0) ng/ml). Both CS exposure systems induced a similar degree of lung function impairment, while inflammation was more severe in whole body exposure system. Slightly more bronchial epithelial damage, mucus and airspace enlargement were observed with the nose-only exposure system. More lymphocytes were present in the bronchoalveolar lavage (BAL) and lymph nodes of the whole-body exposure system while enhanced IgA and IgG production was found in BAL and to a lesser extent in serum with the nose-only exposure system.
The current standardized CS-exposure protocol resulted in a higher internal load of serum cotinine in the whole-body exposure system, which was associated with more inflammation. However, both exposure systems resulted in a similar lung function impairment. Data also highlighted differences between the two models in terms of lung inflammation and remodelling, and potential sensitization to CS. Researchers should be aware of these differences when designing their future studies for an early intervention in COPD.
慢性阻塞性肺疾病(COPD)的特征是肺部发生进行性和异常的炎症反应,主要由吸烟引起。暴露于香烟烟雾(CS)的动物模型被用于模拟人类 COPD,但由于使用不同的 CS 方案,使得比较仅鼻暴露系统和全身暴露系统的免疫和结构后果变得困难。我们假设,当使用基于颗粒密度和 CO(一氧化碳)水平的标准化 CS 暴露方案时,全身 CS 暴露系统会由于通过皮肤或梳理吸收 CS 成分而产生致敏作用,从而比仅鼻暴露系统产生更严重的炎症反应。
在这项针对早期 COPD 的研究中,使用仅鼻或全身暴露系统,每天两次、每周 5 天对小鼠进行 CS 暴露 14 周,以评估肺功能、重塑和炎症。
在牺牲时,全身(5.3(2.3-6.9)ng/ml)暴露系统中的血清可替宁水平明显高于仅鼻(2.0(1.8-2.5)ng/ml)暴露系统和对照组(1.0(0.9-1.0)ng/ml)。两种 CS 暴露系统均导致相似程度的肺功能障碍,而全身暴露系统的炎症更严重。仅鼻暴露系统观察到的支气管上皮损伤、粘液和气道扩张略多。全身暴露系统的支气管肺泡灌洗液(BAL)和淋巴结中存在更多的淋巴细胞,而仅鼻暴露系统在 BAL 和血清中的 IgA 和 IgG 产生增强。
当前的标准化 CS 暴露方案导致全身暴露系统中的血清可替宁内负荷更高,这与更多的炎症有关。然而,两种暴露系统均导致相似的肺功能障碍。数据还突出了两种模型在肺部炎症和重塑方面的差异,以及对 CS 的潜在致敏作用。研究人员在设计 COPD 早期干预的未来研究时应注意这些差异。